{"id":17419,"date":"2023-01-16T08:19:11","date_gmt":"2023-01-16T07:19:11","guid":{"rendered":"https:\/\/www.m-q.ch\/?p=17419"},"modified":"2023-01-16T08:19:11","modified_gmt":"2023-01-16T07:19:11","slug":"pharmaceuticals-switzerland-and-usa-sign-mra","status":"publish","type":"post","link":"https:\/\/www.m-q.ch\/en\/pharmaceuticals-switzerland-and-usa-sign-mra\/","title":{"rendered":"Pharmaceuticals: Switzerland and USA sign MRA"},"content":{"rendered":"<figure id=\"attachment_17420\" aria-describedby=\"caption-attachment-17420\" style=\"width: 680px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-17420\" src=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg\" alt=\"\" width=\"680\" height=\"383\" srcset=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg 680w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ-18x10.jpg 18w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ-375x211.jpg 375w, https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ-621x350.jpg 621w\" sizes=\"auto, (max-width: 680px) 100vw, 680px\" \/><figcaption id=\"caption-attachment-17420\" class=\"wp-caption-text\">After the signing of the MRA GMP for Medicinal Products: From left to right: Andi Fristedt (FDA Deputy Commissioner for Policy, Legislation, and International Affairs), Jayme White (Deputy United States Trade Representative), Helene Budliger Artieda (Director of the State Secretariat for Economic Affairs SECO), Dr. J\u00f6rg Schl\u00e4pfer (Swissmedic, Head of Staff and International Affairs). (Source: Swiss Embassy in Washington DC \/ www.economiesuisse.ch)<\/figcaption><\/figure>\n<p>With a trade volume of 900 billion Swiss francs, the USA is now Switzerland's most important trading partner. The United States is also a major export market for the Swiss pharmaceutical industry: 26 percent of drug exports now cross the Atlantic. Until now, however, trade has been associated with a number of administrative hurdles. For example, drugs must be produced in accordance with internationally agreed Good Manufacturing Practices (GMP). Compliance with these rules is checked twice: in Switzerland by Swissmedic and in the USA by the Food and Drug Administration FDA.\u00a0<\/p>\n<h3>Lower hurdles for drug approval<\/h3>\n<p>The agreement signed on January 12, 2023, now assures mutual recognition (Mutual Recognition Agreement MRA) of GMPs. This means that Swissmedic and the FDA will refrain from inspecting the production facilities of pharmaceutical manufacturers in the other country after an intensive review of the partner state's inspection practices. This is a win-win situation for both sides, because such inspections tie up resources and cost time and money - according to industry association Interpharma, \"quickly more than a million Swiss francs.\" These resources can now be invested in innovation following the elimination of mutual inspections.\u00a0<\/p>\n<p>The agreement removes a so-called non-tariff trade barrier. According to the Federal Department of Economic Affairs, Education and Research (EAER), the GMP MRA also contributes to the diversification of trade relations, including Switzerland's cross-border production and supply chains. In this way, the MRA supports the security of supply and resilience of the Swiss economy, which is dependent on foreign trade, especially in view of the ongoing global upheavals with regard to international trade, according to the statement published on the subject.<\/p>\n<h3>Motion calls for similar MRA for medical devices<\/h3>\n<p>Comparable GMP MRAs already exist between the US and the EU, as well as the UK. Switzerland, for its part, has already concluded GMP MRAs with the EU, the UK, and South Korea. The agreement is intended to create a level playing field for Switzerland as a pharmaceutical location compared to the EU and the UK in the US market. However, medical products that do not fall into the pharmaceutical sector are still excluded. A motion by National Councilor Damian M\u00fcller wants to change this and calls for an MRA with the US and other countries for the approval of medical devices (e.g. insulin pumps, medical protective masks, prostheses, etc.). This is because after the EU's new Medical Devices Regulation comes into force in 2021, Switzerland will be considered a \"third country\" there because there is no framework agreement between Switzerland and the EU. For the approval of medical devices, this means a high administrative hurdle and may lead to certain products no longer being available in Switzerland in the medium to long term.<\/p>\n<p><em>Sources: <a href=\"http:\/\/www.economiesuisse.ch\">economiesuisse<\/a>, <a href=\"https:\/\/www.admin.ch\/gov\/de\/start\/dokumentation\/medienmitteilungen.msg-id-92267.html\">WBF\/Swissmedic<\/a>, <a href=\"http:\/\/www.interpharma.ch\">interpharma<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>With a trade volume of 900 billion Swiss francs, the USA is now Switzerland's most important trading partner. The United States is also a major export market for the Swiss pharmaceutical industry: 26% of exports of medicines now go across the Atlantic. Until now, however, trade has been associated with a number of administrative hurdles. For example, pharmaceuticals have to be [...]<\/p>","protected":false},"author":10,"featured_media":17420,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3303],"tags":[4303,3327,5274,3690],"class_list":["post-17419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-qualitaetsmanagement","tag-pharmaindustrie","tag-qualitaetsmanagement","tag-wirtschaftspolitik","tag-zertifizierung"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Arzneimittel: Schweiz und USA unterzeichnen MRA - MQ Management und Qualit\u00e4t<\/title>\n<meta name=\"description\" content=\"Die Schweiz und die USA unterzeichneten ein Abkommen \u00fcber die gegenseitige Anerkennung der Inspektionen im Bereich der GMP f\u00fcr Arzneimittel.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m-q.ch\/en\/pharmaceuticals-switzerland-and-usa-sign-mra\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arzneimittel: Schweiz und USA unterzeichnen MRA\" \/>\n<meta property=\"og:description\" content=\"Die Schweiz und die USA unterzeichneten ein Abkommen \u00fcber die gegenseitige Anerkennung der Inspektionen im Bereich der GMP f\u00fcr Arzneimittel.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m-q.ch\/en\/pharmaceuticals-switzerland-and-usa-sign-mra\/\" \/>\n<meta property=\"og:site_name\" content=\"MQ Management und Qualit\u00e4t\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ManagementUndQualitaet\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-16T07:19:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"680\" \/>\n\t<meta property=\"og:image:height\" content=\"383\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Thomas Berner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"#Arzneimittel: Schweiz und USA unterzeichnen #MRA\" \/>\n<meta name=\"twitter:description\" content=\"Die #Schweiz und die #USA unterzeichneten ein Abkommen \u00fcber die gegenseitige Anerkennung der Inspektionen im Bereich der #GMP f\u00fcr #Arzneimittel.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Thomas Berner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/\"},\"author\":{\"name\":\"Thomas Berner\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/a8711938b1cfb3f056dec70eaa0b42ab\"},\"headline\":\"Arzneimittel: Schweiz und USA unterzeichnen MRA\",\"datePublished\":\"2023-01-16T07:19:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/\"},\"wordCount\":516,\"publisher\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg\",\"keywords\":[\"Pharmaindustrie\",\"Qualit\u00e4tsmanagement\",\"Wirtschaftspolitik\",\"Zertifizierung\"],\"articleSection\":[\"Qualit\u00e4tsmanagement\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/\",\"url\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/\",\"name\":\"Arzneimittel: Schweiz und USA unterzeichnen MRA - MQ Management und Qualit\u00e4t\",\"isPartOf\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg\",\"datePublished\":\"2023-01-16T07:19:11+00:00\",\"description\":\"Die Schweiz und die USA unterzeichneten ein Abkommen \u00fcber die gegenseitige Anerkennung der Inspektionen im Bereich der GMP f\u00fcr Arzneimittel.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage\",\"url\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg\",\"contentUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg\",\"width\":680,\"height\":383,\"caption\":\"v.l.n.r.: Andi Fristedt (FDA Deputy Commissioner for Policy, Legislation, and International Affairs), Jayme White (Deputy United States Trade Representative), Helene Budliger Artieda (Direktorin des Staatssekretariats f\u00fcr Wirtschaft SECO), Dr. J\u00f6rg Schl\u00e4pfer (Swissmedic, Leiter Bereich Stab und Internationales). (Quelle: Schweizerische Botschaft in Washington D.C. \/ www.economiesuisse.ch)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Qualit\u00e4tsmanagement\",\"item\":\"https:\/\/www.m-q.ch\/kategorie\/qualitaetsmanagement\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arzneimittel: Schweiz und USA unterzeichnen MRA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#website\",\"url\":\"https:\/\/www.m-q.ch\/fr\/\",\"name\":\"MQ Management und Qualit\u00e4t\",\"description\":\"Plattform f\u00fcr integrierte Managementsysteme.\",\"publisher\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.m-q.ch\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#organization\",\"name\":\"Galledia Fachmedien AG\",\"url\":\"https:\/\/www.m-q.ch\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png\",\"contentUrl\":\"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png\",\"width\":512,\"height\":512,\"caption\":\"Galledia Fachmedien AG\"},\"image\":{\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ManagementUndQualitaet\",\"https:\/\/www.linkedin.com\/showcase\/17982321\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/a8711938b1cfb3f056dec70eaa0b42ab\",\"name\":\"Thomas Berner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/faea7857408f70478f976d576da10f96?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/faea7857408f70478f976d576da10f96?s=96&d=mm&r=g\",\"caption\":\"Thomas Berner\"},\"url\":\"https:\/\/www.m-q.ch\/en\/author\/thomas-berner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceuticals: Switzerland and USA sign MRA - MQ Management and Quality","description":"Switzerland and the U.S. signed an agreement on mutual recognition of inspections in the field of GMP for medicinal products.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m-q.ch\/en\/pharmaceuticals-switzerland-and-usa-sign-mra\/","og_locale":"en_US","og_type":"article","og_title":"Arzneimittel: Schweiz und USA unterzeichnen MRA","og_description":"Die Schweiz und die USA unterzeichneten ein Abkommen \u00fcber die gegenseitige Anerkennung der Inspektionen im Bereich der GMP f\u00fcr Arzneimittel.","og_url":"https:\/\/www.m-q.ch\/en\/pharmaceuticals-switzerland-and-usa-sign-mra\/","og_site_name":"MQ Management und Qualit\u00e4t","article_publisher":"https:\/\/www.facebook.com\/ManagementUndQualitaet","article_published_time":"2023-01-16T07:19:11+00:00","og_image":[{"width":680,"height":383,"url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg","type":"image\/jpeg"}],"author":"Thomas Berner","twitter_card":"summary_large_image","twitter_title":"#Arzneimittel: Schweiz und USA unterzeichnen #MRA","twitter_description":"Die #Schweiz und die #USA unterzeichneten ein Abkommen \u00fcber die gegenseitige Anerkennung der Inspektionen im Bereich der #GMP f\u00fcr #Arzneimittel.","twitter_image":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg","twitter_misc":{"Written by":"Thomas Berner","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#article","isPartOf":{"@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/"},"author":{"name":"Thomas Berner","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/a8711938b1cfb3f056dec70eaa0b42ab"},"headline":"Arzneimittel: Schweiz und USA unterzeichnen MRA","datePublished":"2023-01-16T07:19:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/"},"wordCount":516,"publisher":{"@id":"https:\/\/www.m-q.ch\/fr\/#organization"},"image":{"@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg","keywords":["Pharmaindustrie","Qualit\u00e4tsmanagement","Wirtschaftspolitik","Zertifizierung"],"articleSection":["Qualit\u00e4tsmanagement"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/","url":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/","name":"Pharmaceuticals: Switzerland and USA sign MRA - MQ Management and Quality","isPartOf":{"@id":"https:\/\/www.m-q.ch\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage"},"image":{"@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg","datePublished":"2023-01-16T07:19:11+00:00","description":"Switzerland and the U.S. signed an agreement on mutual recognition of inspections in the field of GMP for medicinal products.","breadcrumb":{"@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#primaryimage","url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg","contentUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2023\/01\/Arzneimittel-Schweiz-und-USA-unterzeichnen-MRA_MQ.jpg","width":680,"height":383,"caption":"v.l.n.r.: Andi Fristedt (FDA Deputy Commissioner for Policy, Legislation, and International Affairs), Jayme White (Deputy United States Trade Representative), Helene Budliger Artieda (Direktorin des Staatssekretariats f\u00fcr Wirtschaft SECO), Dr. J\u00f6rg Schl\u00e4pfer (Swissmedic, Leiter Bereich Stab und Internationales). (Quelle: Schweizerische Botschaft in Washington D.C. \/ www.economiesuisse.ch)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.m-q.ch\/arzneimittel-schweiz-und-usa-unterzeichnen-mra\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Qualit\u00e4tsmanagement","item":"https:\/\/www.m-q.ch\/kategorie\/qualitaetsmanagement\/"},{"@type":"ListItem","position":2,"name":"Arzneimittel: Schweiz und USA unterzeichnen MRA"}]},{"@type":"WebSite","@id":"https:\/\/www.m-q.ch\/fr\/#website","url":"https:\/\/www.m-q.ch\/fr\/","name":"MQ Management and Quality","description":"Platform for integrated management systems.","publisher":{"@id":"https:\/\/www.m-q.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m-q.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.m-q.ch\/fr\/#organization","name":"Galledia Trade Media AG","url":"https:\/\/www.m-q.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png","contentUrl":"https:\/\/www.m-q.ch\/wp-content\/uploads\/2020\/12\/cropped-logo_small.png","width":512,"height":512,"caption":"Galledia Fachmedien AG"},"image":{"@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ManagementUndQualitaet","https:\/\/www.linkedin.com\/showcase\/17982321\/admin\/"]},{"@type":"Person","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/a8711938b1cfb3f056dec70eaa0b42ab","name":"Thomas Bernard","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m-q.ch\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/faea7857408f70478f976d576da10f96?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/faea7857408f70478f976d576da10f96?s=96&d=mm&r=g","caption":"Thomas Berner"},"url":"https:\/\/www.m-q.ch\/en\/author\/thomas-berner\/"}]}},"_links":{"self":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts\/17419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/comments?post=17419"}],"version-history":[{"count":1,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts\/17419\/revisions"}],"predecessor-version":[{"id":17421,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/posts\/17419\/revisions\/17421"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/media\/17420"}],"wp:attachment":[{"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/media?parent=17419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/categories?post=17419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m-q.ch\/en\/wp-json\/wp\/v2\/tags?post=17419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}